DIABETIC KIDNEY DISEASE MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Regional Analysis

To learn more about this report, request sample copy

North America region has been dominating the global diabetic kidney disease market over the years and is projected to hold 38.2% of the market share in 2024. The U.S. accounts for the largest share primarily due to t rising prevalence of diabetes as well as better access to healthcare and advanced treatment options in the country. The economic ability and healthcare infrastructure in the region allow for large investments in R&D which has led to the development of innovative drugs and new treatment modalities. Most of the leading pharmaceutical players have their headquarters in the U.S. and focus on drug innovation for diabetic kidney disease. This has ensured early availability and adoption of new treatment options.

The Asia Pacific region has emerged as the fastest growing market for diabetic kidney disease treatment globally. Countries like China, India and Japan are experiencing rapid economic development and growth of medical infrastructure. While Asia has a lower rate of diagnosed cases currently due to lack of screening, the prevalence of diabetes is rising sharply due to expanding urbanization and lifestyle changes. Asia Pacific accounted for over 60% of the world's diabetic population in 2019. Rising awareness, screening programs and availability of affordable generic drugs are driving the market growth. Governments are also investing in initiatives to expand health insurance coverage thus, driving the market growth.